Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention
Qi Zhang, Jing Pan, Donghai Xiong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 28
Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer
S.P. SINGH, Sangeeta Saxena, Himani Sharma, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155222-155222
Closed Access | Times Cited: 10
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
Ana Dillen, Indy Bui, Megan Jung, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1237-1237
Open Access | Times Cited: 5
MAF1 inhibits hepatocarcinogenesis by fostering an immunostimulatory tumor microenvironment
Di Cao, Yue-Ning Wang, Chao‐Yue Sun, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009656-e009656
Open Access
Defining precancer: a grand challenge for the cancer community
Jessica M. Faupel‐Badger, Indu Kohaar, Manisha Bahl, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 4
PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer
Fatemeh Tajic Rostami, Zahra Tavakol Hamedani, Azadeh Sadoughi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Mechanism research of non‐coding RNA in immune checkpoint inhibitors therapy
Jie Bian, Rui Shao, Juan Li, et al.
Cancer Science (2024) Vol. 115, Iss. 11, pp. 3520-3531
Open Access | Times Cited: 2
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications
Mohamed S. Kishta, Aya Khamis, Hafez Am, et al.
Translational Oncology (2024) Vol. 51, pp. 102216-102216
Closed Access | Times Cited: 2
Sodium tanshinone IIA sulfonate inhibits tumor growth via miR-138 upregulation in intermittent hypoxia-induced xenograft mice
Xiao‐Bin Zhang, Qi-Feng Gan, Xiuzhen He, et al.
Aging (2024) Vol. 16, Iss. 4, pp. 3231-3240
Open Access | Times Cited: 1
Pyroptosis in Lung Cancer: The Emerging Role of Non-Coding RNAs
Lakshmi Thangavelu, Ahsas Goyal, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155619-155619
Closed Access
Identification and Validation of circDOCK1/miR-138-5p/GRB7 Axis for Promoting Breast Cancer Progression
Yan Zhang, Mei Yang, Yiping Wang, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 795-810
Open Access
Page 1

Scroll to top